Treatment usually begins with a low dose, which can later be adjusted by a doctor to balance effectiveness and tolerability
Real-world reports of nighttime sweating are more common than the official rate suggests, likely because many patients don't report mild symptoms
You dont need to worry about it
That single fact shapes everything about how the blend can honestly be described
To ensure that findings are generalizable, key next steps will be to replicate and extend this work with variations of the target (e.g., gender, race/ethnicity, prior attempts at weight loss, cost paid for medication) and diverse groups of participants, both in terms of participant demographics and preexisting knowledge of GLP-1s (e.g., general population, eligible patients, healthcare professionals)